{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:16:15Z","timestamp":1788243375154,"version":"build-2803163510"},"reference-count":82,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Cardiovascular complications of cancer therapy may affect patients far beyond conventional measures of cardiac function, yet their relationship with health-related quality of life (HRQoL) remains incompletely defined. This review examined how cardiovascular status and cardiotoxicity-related interventions relate to HRQoL across cancer treatment and survivorship. Methods: Twenty-one studies were reviewed and reassessed according to four research questions: established cardiovascular disease or cardiac dysfunction and HRQoL; subclinical cardiovascular abnormalities and subsequent HRQoL; interventions targeting cardiotoxicity with HRQoL assessment; and supportive interventions improving HRQoL without demonstrated cardioprotection. Evidence was additionally considered across diagnostic, pharmacological\/cardioprotective, exercise, and supportive-care domains. Results: The available evidence revealed a clinically relevant pattern. Established cardiovascular disease or cardiac dysfunction showed the clearest association with poorer HRQoL, particularly in physical domains, whereas evidence linking subclinical abnormalities to subsequent patient-reported deterioration was sparse. Most studies evaluated interventions, including cardioprotective pharmacological strategies and exercise-based approaches, but improvements in HRQoL were not consistently accompanied by, or attributable to, demonstrated cardioprotection. Exercise and supportive interventions were also associated with improvements in functional or patient-reported outcomes in some studies, independently of demonstrable cardiovascular benefit. Across domains, substantial heterogeneity in populations, cardiovascular measures, interventions, HRQoL instruments, and study designs limited direct comparison and causal interpretation. Conclusions: Cardiovascular health and HRQoL appear closely interconnected, but the available evidence does not establish a consistent link between cardiovascular injury and subsequent changes in HRQoL. The literature is richer in prevention and intervention studies than in longitudinal assessment of the patient-reported consequences of cardiovascular injury. Larger prospective studies incorporating standardized serial cardiovascular assessment and HRQoL as a predefined primary endpoint are needed to establish temporal relationships and clinically meaningful cardiovascular determinants of HRQoL.<\/jats:p>","DOI":"10.3390\/jcm15176760","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:45:13Z","timestamp":1788241513000},"page":"6760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Balancing Oncological Care and Quality of Life: Diagnostic and Therapeutic Strategies for Chemotherapy-Induced Cardiotoxicity\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Alexandra","family":"Huiduc","sequence":"first","affiliation":[{"name":"Department of Medical Semiology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4112-083X","authenticated-orcid":false,"given":"Ovidiu","family":"Popa-Velea","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Mihaela","family":"Ilie\u0219iu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cProf. Dr. Theodor Burghele\u201d Clinical Hospital, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: A common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_6","unstructured":"IQVIA Institute for Human Data Science (2023). Global Oncology Trends 2023, IQVIA Institute for Human Data Science."},{"key":"ref_7","first-page":"791","article-title":"Symptoms and treatment burden associated with cancer treatment: Results from a cross-sectional national survey in the U.S","volume":"16","author":"Henry","year":"2008","journal-title":"Support. Care Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaccao.2023.11.004","article-title":"Growing, Building, and Defining the Field of Cardio-Oncology for Our Patients","volume":"5","author":"Ky","year":"2023","journal-title":"JACC CardioOncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaccao.2024.09.002","article-title":"Priorities in Cardio-Oncology: Filling the Gaps in Evidence","volume":"6","author":"Ky","year":"2024","journal-title":"JACC CardioOncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (ICOS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaccao.2023.06.002","article-title":"Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To","volume":"5","author":"Fradley","year":"2023","journal-title":"JACC CardioOncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaccao.2023.10.010","article-title":"Cardio-Oncology Care Delivery for All Patients With Cancer Within Academic and Community Settings","volume":"6","author":"Jacobs","year":"2024","journal-title":"JACC CardioOncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","article-title":"Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis","volume":"49","author":"Kalam","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s11136-014-0732-6","article-title":"Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment","volume":"23","author":"Cella","year":"2014","journal-title":"Qual. Life Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"NP681","DOI":"10.1177\/1010539513496138","article-title":"Gaps in Health-Related Quality of Life Among Survivors of Cancer and Cardiovascular Disease: The Korean National Health and Nutrition Examination Survey, 2005 (KNHANES III)","volume":"27","author":"Hwang","year":"2015","journal-title":"Asia Pac. J. Public Health"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Buziashvili, Y.I., Stilidi, I.S., Asymbekova, E.U., Matskeplishvili, S.T., Tugeeva, E.F., Akhmedyarova, N.K., Artamonova, E.V., and Akildzhonov, F.R. (2024). Comprehensive assessment of the quality of life in patients with breast cancer during neoadjuvant chemotherapy. Heart Vessel. Transplant., 8.","DOI":"10.24969\/hvt.2024.452"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2478\/sjph-2021-0028","article-title":"Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients","volume":"60","author":"Kukec","year":"2021","journal-title":"Slov. J. Public Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.22.01016","article-title":"Cardiovascular disease in testicular cancer survivors: Identification of risk factors and impact on quality of life","volume":"41","author":"Lubberts","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_24","first-page":"1288","article-title":"Efficacy of ifosfamide combined with liposome doxorubicin on osteosarcoma and its effects on serum IL-10, TNF-\u03b1, and IFN-\u03b3 in patients with osteosarcoma","volume":"14","author":"Huang","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1093\/oncolo\/oyab065","article-title":"HeRandomized phase II study of two doses of pixantrone in patients with metastatic breast cancer (NCCTG N1031, Alliance)","volume":"27","author":"Sideras","year":"2022","journal-title":"Oncologist"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/cncr.20400","article-title":"Concomitant versus sequential administration of epirubicin and paclitaxel","volume":"101","author":"Conte","year":"2004","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cjco.2024.03.007","article-title":"Safety of continuing trastuzumab for mild cardiotoxicity: A cardiovascular magnetic resonance imaging study","volume":"6","author":"Suntheralingam","year":"2024","journal-title":"CJC Open"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1200\/JCO.2017.74.1165","article-title":"Long-term follow-up of cardiac function and quality of life for patients in NSABP Protocol B-31\/NRG Oncology","volume":"35","author":"Ganz","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","article-title":"The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research","volume":"49","author":"Sangha","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/jnci\/87.18.1372","article-title":"Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial","volume":"87","author":"Ganz","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.32471\/exp-oncology.2312-8852.vol-41-no-4.13906","article-title":"How to Improve Quality of Life in Patients with Acute Leukemia and Comorbid Ischemic Heart Disease Treated with Anthracycline-Based Induction Chemotherapy","volume":"41","author":"Skrypnyk","year":"2019","journal-title":"Exp. Oncol."},{"key":"ref_32","first-page":"1","article-title":"Exercise to Prevent Anthracycline-Based Cardiotoxicity (EXACT): A Feasibility Study","volume":"6","author":"Keats","year":"2021","journal-title":"Transl. J. Am. Coll. Sports Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1728-869X(11)60009-9","article-title":"Exercise intervention for cancer survivors with heart failure: Two case reports","volume":"9","author":"Hughes","year":"2011","journal-title":"J. Exerc. Sci. Fit."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40814-024-01580-7","article-title":"Physical activity intervention in lymphoma patients","volume":"11","author":"Costa","year":"2025","journal-title":"Pilot Feasibility Stud."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15347354231210874","DOI":"10.1177\/15347354231210874","article-title":"Impact of aerobic training on cardiovascular function, fitness, and patient reported outcomes during anthracycline chemotherapy","volume":"22","author":"Murray","year":"2023","journal-title":"Integr. Cancer Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.57187\/s.3588","article-title":"Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy","volume":"154","author":"Schneider","year":"2024","journal-title":"Swiss Med. Wkly."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaccao.2022.06.006","article-title":"Self-reported physical activity, quality of life, cardiac function, and cardiorespiratory fitness in women with HER2+ breast cancer","volume":"4","author":"Peck","year":"2022","journal-title":"JACC CardioOncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pcad.2024.02.002","article-title":"Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention","volume":"85","year":"2024","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1534735420969818","DOI":"10.1177\/1534735420969818","article-title":"Home-Based Physical Activity in Patients With Breast Cancer: During and\/or After Chemotherapy? Impact on Cardiorespiratory Fitness. A 3-Arm Randomized Controlled Trial (APAC)","volume":"19","author":"Vincent","year":"2020","journal-title":"Integr. Cancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1534735413503546","article-title":"Home-based motivational exercise program for African American breast cancer survivors","volume":"13","author":"Spector","year":"2014","journal-title":"Integr. Cancer Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1002\/cncr.24551","article-title":"Impact of a Walking Intervention on Cardiorespiratory Fitness, Self-Reported Physical Function, and Pain in Patients Undergoing Treatment for Solid Tumors","volume":"115","author":"Griffith","year":"2009","journal-title":"Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/eurjcn\/zvab057","article-title":"Quality of life in breast cancer patients with cardiac dysfunction","volume":"21","author":"Koop","year":"2022","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1188\/19.ONF.E145-E158","article-title":"Anthracycline chemotherapy-induced cardiotoxicity in breast cancer survivors: A systematic review","volume":"46","author":"Lin","year":"2019","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_44","first-page":"227","article-title":"Anthracycline cardiotoxicity after breast cancer treatment","volume":"23","author":"Hershman","year":"2009","journal-title":"Oncology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s11764-025-01757-w","article-title":"Relationship between incident cardiovascular disease and quality of life after a breast cancer diagnosis","volume":"20","author":"Vasbinder","year":"2025","journal-title":"J. Cancer Surviv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cardfail.2024.08.045","article-title":"Cardio-Oncology and Heart Failure: A Scientific Statement From the Heart Failure Society of America","volume":"31","author":"Bloom","year":"2025","journal-title":"J. Card. Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/ejhf.70005","article-title":"Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology","volume":"27","author":"Keramida","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/ejhf.3753","article-title":"Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology","volume":"27","author":"Rakisheva","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pcad.2025.01.001","article-title":"Global longitudinal strain as an early marker of cardiac damage after cardiotoxic medications, a state-of-the-art review","volume":"89","author":"Sartorio","year":"2025","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40959-025-00371-0","article-title":"Integrative speckle-tracking echocardiography for the early detection and prediction of cancer therapy-related cardiac dysfunction","volume":"11","author":"Qiu","year":"2025","journal-title":"Cardio-Oncology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40959-025-00373-y","article-title":"Strain-derived myocardial work indices in adult cancer survivors: Results from an observational study and comparison with available reference ranges","volume":"11","author":"Camilli","year":"2025","journal-title":"Cardio-Oncology"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Migliari, M., Fazzini, L., Campana, N., Deidda, M., Dess\u00ec, M., and Cadeddu Dessalvi, C. (2025). Current strategies for prevention of cancer therapy-related cardiotoxicity: Pharmacological, non-pharmacological and emerging approaches. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1668308"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"104997","DOI":"10.1016\/j.ijnurstu.2025.104997","article-title":"Effectiveness of Exercise-Based Interventions in Preventing Cancer Therapy-Related Cardiac Dysfunction in Patients with Breast Cancer: A Systematic Review and Network Meta-Analysis","volume":"163","author":"Zhang","year":"2025","journal-title":"Int. J. Nurs. Stud."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101954","DOI":"10.1016\/j.rehab.2025.101954","article-title":"Effects of Exercise-Based Interventions on Health-Related Quality of Life in Adults after Cancer: A Systematic Review and Meta-Analysis","volume":"68","author":"Ruiz","year":"2025","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/eurheartj\/ehaf100","article-title":"Cardio-oncology rehabilitation and exercise: Evidence, priorities, and research standards from the ICOS-CORE working group","volume":"46","author":"Adams","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1200\/JCO.2017.77.5809","article-title":"Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis","volume":"36","author":"Scott","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/epirev\/mxx007","article-title":"The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects","volume":"39","author":"Cormie","year":"2017","journal-title":"Epidemiol. Rev."},{"key":"ref_59","first-page":"468","article-title":"Exercise Is Medicine in Oncology: Engaging Clinicians to Help Patients Move through Cancer","volume":"69","author":"Schmitz","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.15190\/d.2025.16","article-title":"Chemotherapy-Induced Cardiotoxicity: Mechanisms, Detection and Emerging Therapies in Cardio-Oncology","volume":"13","author":"Goveo","year":"2025","journal-title":"Discoveries"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.31925\/farmacia.2021.6.5","article-title":"Cardiotoxicity of Anticancer Therapies: Focus on the Role of the Cardio-Oncological Team. A Practical Review","volume":"69","author":"Gheorghe","year":"2021","journal-title":"Farmacia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/ehf2.13795","article-title":"Living with heart failure: Patient experiences and implications for physical activity and daily living","volume":"9","author":"Niklasson","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","article-title":"The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review","volume":"4","author":"Omland","year":"2022","journal-title":"JACC CardioOncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40959-024-00284-4","article-title":"SGLT2 inhibitors for prevention and management of cancer treatment-related cardiovascular toxicity: A review of potential mechanisms and clinical insights","volume":"11","author":"Simela","year":"2025","journal-title":"Cardio-Oncology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40959-023-00159-0","article-title":"Efficacy and Safety of Cardioprotective Drugs in Chemotherapy-Induced Cardiotoxicity: An Updated Systematic Review & Network Meta-Analysis","volume":"9","author":"Mir","year":"2023","journal-title":"Cardio-Oncology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","article-title":"Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e018403","DOI":"10.1161\/JAHA.120.018403","article-title":"Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines","volume":"9","author":"Alexandre","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.acvd.2024.12.012","article-title":"Diagnosis of Cancer Therapy-Related Cardiovascular Toxicities: A Multimodality Integrative Approach and Future Developments","volume":"118","author":"Travers","year":"2025","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/eurheartj\/ehaf052","article-title":"An Update on the European Society of Cardiology Council of Cardio-Oncology","volume":"46","author":"Lyon","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaccao.2024.11.003","article-title":"Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective","volume":"7","author":"Rao","year":"2025","journal-title":"JACC CardioOncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2019.06.004","article-title":"Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial","volume":"1","author":"Leong","year":"2019","journal-title":"JACC CardioOncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.35693\/SIM634107","article-title":"Treatment of Cardiotoxicity in Patients with Invasive Breast Cancer during Neoadjuvant Chemotherapy","volume":"9","author":"Ignatenko","year":"2024","journal-title":"Sci. Innov. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000535737","article-title":"Exercise and cardiotoxicity meta-analysis","volume":"102","author":"Chiang","year":"2024","journal-title":"Oncology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.123.323346","article-title":"Exercise Inhibits Doxorubicin-Induced Cardiotoxicity via Regulating B Cells","volume":"134","author":"Wang","year":"2024","journal-title":"Circ. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.1038\/s41598-024-63431-y","article-title":"Psychological intervention improves quality of life in patients with early-stage cancer: A systematic review and meta-analysis of randomized clinical trials","volume":"14","author":"Teutsch","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1002\/cam4.70063","article-title":"The efficacy of cognitive behavioral therapy for mental health and quality of life among individuals diagnosed with cancer: A systematic review and meta-analysis","volume":"13","author":"Dils","year":"2024","journal-title":"Cancer Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102923","DOI":"10.1016\/j.ejon.2025.102923","article-title":"Effects of a Multi-Component Positive Psychological Intervention on Negative Emotions, Fatigue and Quality of Life in Patients with Breast Cancer during Initial Chemotherapy: A Randomized Controlled Trial","volume":"77","author":"Wang","year":"2025","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1650S","DOI":"10.1093\/jn\/137.6.1650S","article-title":"The pharmacodynamics of L-arginine","volume":"137","year":"2007","journal-title":"J. Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ncpcardio0878","article-title":"Mechanisms of Disease: L-Arginine in Coronary Atherosclerosis\u2014A Clinical Perspective","volume":"4","author":"Tousoulis","year":"2007","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaccao.2025.07.008","article-title":"Diet and Prevention of Cardiovascular Disease and Cancer: JACC: CardioOncology State-of-the-Art Review","volume":"7","author":"Hull","year":"2025","journal-title":"JACC CardioOncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ehjdh\/ztae082","article-title":"Mobile\/wearable digital devices for care of active cancer patients: A survey from the ESC Council of Cardio-Oncology","volume":"6","author":"Boriani","year":"2025","journal-title":"Eur. Heart J. Digit. Health"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:58:29Z","timestamp":1788242309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":82,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176760"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176760","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}